Search by Drug Name or NDC
NDC 70710-1194-08 Estradiol 0.075 mg/d Details
Estradiol 0.075 mg/d
Estradiol is a TRANSDERMAL PATCH, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is ESTRADIOL.
MedlinePlus Drug Summary
Transdermal estradiol (Climara, Minivelle, Vivelle-Dot) is used to treat hot flashes (hot flushes; sudden feelings of mild or intense body heat) in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol (Climara, Vivelle-Dot) is also used to treat vaginal dryness, itching, and burning in women who are experiencing menopause. Transdermal estradiol (Climara, Menostar, Minivelle, Vivelle-Dot) is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause. Transdermal estradiol (Climara, Vivelle-Dot) is also used as a source of estrogen in women have not yet experienced menopause and who do not produce enough estrogen naturally. Women whose only bothersome symptoms are vaginal dryness, itching, or burning may benefit more from an estrogen product that is applied topically to the vagina. Women who only need a medication to prevent osteoporosis may benefit more from a different medication that does not contain estrogen. Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body.
Related Packages: 70710-1194-08Last Updated: 05/12/2024
MedLinePlus Full Drug Details: Estradiol Transdermal Patch
Product Information
NDC | 70710-1194 |
---|---|
Product ID | 70710-1194_fabe46eb-9f99-46e5-bedd-677cc99a024d |
Associated GPIs | |
GCN Sequence Number | 023270 |
GCN Sequence Number Description | estradiol PATCH TDSW .075MG/24H TRANSDERM |
HIC3 | G1A |
HIC3 Description | ESTROGENIC AGENTS |
GCN | 28843 |
HICL Sequence Number | 001421 |
HICL Sequence Number Description | ESTRADIOL |
Brand/Generic | Generic |
Proprietary Name | Estradiol |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Estradiol |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | PATCH, EXTENDED RELEASE |
Route | TRANSDERMAL |
Active Ingredient Strength | 0.075 |
Active Ingredient Units | mg/d |
Substance Name | ESTRADIOL |
Labeler Name | Zydus Pharmaceuticals USA Inc. |
Pharmaceutical Class | Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA206241 |
Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1194-08 (70710119408)
NDC Package Code | 70710-1194-8 |
---|---|
Billing NDC | 70710119408 |
Package | 8 POUCH in 1 BOX (70710-1194-8) / 1 PATCH in 1 POUCH (70710-1194-1) / 3.5 d in 1 PATCH |
Marketing Start Date | 2023-04-13 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 7.14055 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | ESTRADIOL 0.075 MG PATCH(2/WK) |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |